- Total net sales for the quarter were $3.2 billion, which is up 3.1% compared to the corresponding period of 2022
- Net income came in at $137 million or $1.05 per share in Q3, vs. $150 million or $1.09 per share in the year-ago quarter
- Adjusted earnings, excluding special items, was $173 million or $1.32 per share, vs. $177 million or $1.29 per share in Q3 2022
- Global Dental sales came in at $1.9 billion in Q3, an increase of 5.4% from the prior-year period
- Global Medical sales moved up 3.1% annually to $1.1 billion during the three-month period
- At $120 million, Global Technology and Value-Added Services sales were up 18.8% year-over-year
- The company invested $417 million in business acquisitions during the third quarter and $668 million year-to-date
Market News
Earnings Summary: Henry Schein (HSIC) Q3 2023 financial results
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter of 2023. Total net sales for the quarter were $3.2 billion, which is up 3.1% compared to the corresponding period of 2022 Net income came in at $137 million or $1.05 per share in Q3, vs. $150 million […]
NYSE
$HSIC · Earnings
“Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter of 2023. Total net sales for the quarter were $3.2 billion, which is up 3.1% compared to the corresponding period of 2022 Net income came in at $137 million or $1.05 per share in Q3, vs. $150 million […]
· November 13, 2023
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter of 2023.
ADVERTISEMENT